Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ENO2 |
| Upstream (Parents) |
|---|
| (<<) PKM2 → ENO2 |
| (<<) ALDOA → ENO2 |
| (<<) MAFF → ENO2 |
| Downstream (Children) |
|---|
| ENO2 → ERO1L (>>) |
| ENO2 → FOSL2 (>>) |
| ENO2 → ISG20 (>>) |
| ENO2 → EGLN3 (>>) |
| ENO2 → ACE (>>) |
| ENO2 → BAZ2A (>>) |
| ENO2 → CPB1 (>>) |
| ENO2 → LPCAT1 (>>) |
| ENO2 → THRAP3 (>>) |
| ENO2 → EVX1 (>>) |
| ENO2 → NEDD9 (>>) |
| ENO2 → DDIT4 (>>) |
| ENO2 → SLC6A8 (>>) |
| ENO2 → SEMA3B (>>) |
| ENO2 → SSX5 (>>) |
| ENO2 → PDK3 (>>) |
| ENO2 → RASA4P///RASA4 (>>) |
| ENO2 → NTNG1 (>>) |
| ENO2 → WSB1 (>>) |
| ENO2 → AMIGO2 (>>) |
| ENO2 → NDRG4 (>>) |
| ENO2 → PAQR6 (>>) |
| ENO2 → CRIP1 (>>) |
| ENO2 → PFKFB3 (>>) |
